Clinical Trial Update: Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated the efficacy of a fluocinolone acetonide intravitreal implant for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• fluocinolone acetonide intravitreal implant (fluocinolone acetonide)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: COMPLETED